Virax Holdings has completed a $3 million equity placement to sophisticated investors to support its acquisition last week of Pathway Oncology.
25/03/2014 - 12:10
Virax raises $3m for Pathway takeover
25/03/2014 - 12:10
Related Data & Insights
-
Prescient TherapeuticsClosing price for the last 90 trading daysPowered by Morningstar ®
-
Rank Company Revenue 926th Prescient Therapeutics $2.4m 1115th Lifespot Health $107k 1117th TTA Holdings $107k 1120th County International $98k 1121st Papyrus Australia $98k 1328 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX